Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis

Israel Medical Association Journal

Volumn 9, Issue 11, 2007, Pages 787-790

  Nesher, Eviatar ^a,b   Greenberg, Ron ^a,b   Avital, Shmuel ^a,b   Skornick, Yehuda ^a,b   Schneebaum, Schlomo ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Colorectal carcinoma; Intraperitoneal hyperthermic perfusion; Patient selection; Peritoneal carcinomatosis; Peritoneal mesothelioma; Pseudomyxoma peritonei

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; MITOMYCIN C; OXALIPLATIN; PACLITAXEL; THALIDOMIDE;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER SIZE; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; FEVER; HUMAN; HYPERTHERMIC THERAPY; LEUKOPENIA; MALE; MESOTHELIOMA; MINIMAL RESIDUAL DISEASE; OVARY CANCER; PARALYTIC ILEUS; PATIENT SAFETY; PATIENT SELECTION; PERITONEUM PSEUDOMYXOMA; PLEURA EFFUSION; QUALITY OF LIFE; SEPSIS; SURGICAL MORTALITY; SURVIVAL TIME; TEMPERATURE MEASUREMENT;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MESOTHELIOMA; MIDDLE AGED; PERITONEAL NEOPLASMS; TREATMENT OUTCOME;

EID: 36749052843     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Jackon SL, Fleming RA, Loggie BW, Geisiner KR. Gelatinous ascites: a cytohistologic study of pseudomyxoma peritonei in 67 patients. Mod Pathol 2001;14:664-71.
2. Deraco M, Casali P, Kusamura S Peritoneal mesotheliorna treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion. J Surg Oncol 2003;83:147-53.
3. Deraco M, Nonaka D, Baratti D, Kusamura S. Prognostic analysis of chnicopathologic factors in 49 patients with diffuse malignant peritoneal mesotheliorna treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2006;13: 229-37.
4. Schneebaum S, Arnold MW, Martin EW Jr. Intraperitoneal hyperthermic perfusion with mitomycin C for colorectat cancer with peritoneal metastases. Ann Surg Oncol 1996;3:44-50.
5. Sugarbaker PH, Graves T, DeBruijn EA. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer pharmacological studies. Cancer 1990;50:5790-4.
6. Sugarbaker PH, Zhu BW, Shmookler B. Peritoneal carcinomatosis from appendiceal cancer: results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy. Dis Colon Rectum 1993;36:323-9.
7. Sadeghi B, Arvieux C, Gilly F. Peritoneat carcinomatosis from non-gynecologic malignancies. Results of the EVOCAPE 1 Multicentric Prospective Study. American Cancer Society, 2000.
8. Sutton SW, Yancey LW, Chase VA, Hunley EK, Loggie BW. Intraoperative modality of treatment for peritonea] carcinomatosis: use of hyperthermic intraperitoneal chemoperfusion. Pefusion 2002;17:441-6.
9. McQuellon RP, Loggie BW, Fleming RA, Russell GB, Rambo TD. Quality of life after intrapentoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Eur J Surg Oncol 2001,27:65-73.
10. Loggie BW, Fleming RA, Geisinger KR. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg 2000;66:561-8.
11. Verwaal VJ. Cytoreduction and HIPEC for peritoneal carcinomatosis from colorectal origin: the Amsterdam experience. Acta Chir Belg 2006;106:283-4.
12. Verwaal VJ, Van Tinteren H, Van Ruth S, Zoetmulder FA. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg 2004;91:739-46.